Infection-induced arthritis

Published:December 02, 2021DOI:https://doi.org/10.1016/j.paed.2021.11.002

      Abstract

      It is not uncommon for children and young people to present with evidence of joint inflammation and recent infection. Microorganisms can influence the development of arthritis through numerous mechanisms. The reactive arthritis syndrome classically refers to sterile joint inflammation, sometimes accompanied by extra-articular symptoms like uveitis, which manifests after recent infection of the gastrointestinal or genitourinary systems. Once the diagnosis is made, reactive arthritis can often be managed supportively as most children and young people experience quick resolution of their disease. A small proportion will continue with persistent arthritis and may evolve into a phenotype of enthesitis-related arthritis (a subtype of juvenile idiopathic arthritis) or juvenile ankylosing spondylitis. Important differential diagnoses include the Streptococcus-associated arthritides and Lyme disease, both of which respond to antibiotic treatment. In this review we summarize the latest developments in the understanding of reactive arthritis aetiology (including the roles of the human leucocyte antigen B27 genotype and the microbiome) and highlight the key features to help clinicians identify reactive arthritis and other post-infectious arthritides.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Paediatrics and Child Health
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kingsley G.
        • Sieper J.
        Third international workshop on reactive arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts.
        Ann Rheum Dis. 1996; 55: 564-584
        • Shulman S.T.
        Rheumatic fever.
        in: Kliegman Stanton Geme St Schor Nelson textbook of pediatrics. 20 edn. 1. Elsevier, Philadelphia2016: 1332-1336
        • Antoniou A.N.
        • Lenart I.
        • Kriston-Vizi J.
        • et al.
        Salmonella exploits HLA-B27 and host unfolded protein responses to promote intracellular replication.
        Ann Rheum Dis. 2019; 78: 74-82
        • Manasson J.
        • Shen N.
        • Garcia Ferrer H.R.
        • et al.
        Gut microbiota perturbations in reactive arthritis and postinfectious spondyloarthritis.
        Arthritis Rheumatol. 2018; 70: 242-254
        • Weston A.L.
        • Lane A.T.
        • Morelli J.G.
        Color textbook of pediatric dermatology.
        3rd edn. Mosby, St. Louis2002
        • Kim P.S.
        • Klausmeier T.L.
        • Orr D.P.
        Reactive arthritis: a review.
        J Adolesc Health. 2009; 44: 309-315https://doi.org/10.1016/j.jadohealth.2008.12.007

      Further reading

        • Clegg D.O.
        • Reda D.J.
        • Weisman M.H.
        • et al.
        Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study.
        Arthritis Rheum. 1996; 39: 2021-2027https://doi.org/10.1002/art.1780391211
        • Gewitz M.H.
        • Baltimore R.S.
        • Tani L.Y.
        • et al.
        Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association.
        Circulation. 2015; 131: 1806-1818https://doi.org/10.1161/CIR.0000000000000205
        • Petty R.E.
        • Southwood T.R.
        • Manners P.
        • et al.
        International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.
        J Rheumatol. 2004; 31 (Retrieved from): 390-392
        • Sieper J.
        • Rudwaleit M.
        • Braun J.
        • van der Heijde D.
        Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays.
        Arthritis Rheum. 2002; 46: 319-327https://doi.org/10.1002/art.504
        • Sureja N.P.
        • Nandamuri D.
        Reactive arthritis after SARS-CoV-2 infection.
        Rheumatol Adv Pract. 2021; 5 (rkab001-rkab001 https://doi.org/10.1093/rap/rkab001)